Drug discovery is rapidly moving beyond traditional immortalised cell lines toward advanced models that better mimic the complexity of the human body. Organoids, spheroids, and other physiologically relevant systems are opening new possibilities for more accurate drug discovery and toxicology studies.
This one-day ELRIG forum brings together experts from academia, biotech, and pharma to explore the latest innovations in organoid models, organ-on-a-chip technology, automation, and high-throughput screening. We’ll focus on how these technologies are being applied in disease modelling, safety assessment, and real-world drug development.
Join us to hear case studies from industry and academic researchers on improving drug candidate selection, reducing late-stage failures, and enhancing the predictive power of preclinical testing. The forum will also explore the challenges and opportunities of integrating these models into the drug development pipeline.